PDB33 Using the PRIME Type 2 Diabetes Model to Compare Models of Renal Failure

2021 ◽  
Vol 24 ◽  
pp. S83
Author(s):  
R. Pollock ◽  
W. Valentine
Keyword(s):  
Type 2 Diabetes ◽  
Renal Failure ◽  
Prime Type ◽  
Diabetes Model

scholarly journals Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Sophie Bauer ◽  
Charlotte Wennberg Huldt ◽  
Kajsa P. Kanebratt ◽  
Isabell Durieux ◽  
Daniela Gunne ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Pancreatic Islets ◽  
Ex Vivo ◽  
Functional Coupling ◽  
Human Pancreatic Islets ◽  
Diabetes Model

scholarly journals PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

2012 ◽  
Vol 15 (7) ◽  
pp. A470 ◽  
Author(s):  
V. Foos ◽  
J.L. Palmer ◽  
D. Grant ◽  
A. Lloyd ◽  
M. Lamotte ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Model

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

2005 ◽  
Vol 45 (2) ◽  
pp. 281-287 ◽  
Author(s):  
Robert C. Atkins ◽  
Esther M. Briganti ◽  
Julia B. Lewis ◽  
Lawrence G. Hunsicker ◽  
Gregory Braden ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Renal Failure ◽  
Type 2 Diabetes Mellitus ◽  
Overt Nephropathy

scholarly journals Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs

2019 ◽  
Vol 5 (1) ◽  
pp. 27-30 ◽  
Author(s):  
Thomas A Zelniker ◽  
Eugene Braunwald
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Renal Failure ◽  
Cardiovascular Death ◽  
Cardiovascular Outcomes ◽  
Sodium Glucose Cotransporter ◽  
Increased Risk ◽  
Patients With Diabetes ◽  
Glucagon Like Peptide 1

Patients with type 2 diabetes are at increased risk of developing heart failure, cardiovascular death and renal failure. The recent results of three large sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials have demonstrated a reduction in heart failure hospitalisation and progressive renal failure. One trial also showed a fall in cardiovascular and total death. A broad spectrum of patients with diabetes benefit from these salutary effects in cardiac and renal function and so these trials have important implications for the management of patients with type 2 diabetes. Selected glucagon-like peptide 1 receptor agonists have also been shown to reduce adverse cardiovascular outcomes.

scholarly journals 1,25-Dihydroxy vitamin D3 treatment attenuates osteopenia, and improves bone muscle quality in Goto-Kakizaki type 2 diabetes model rats

Endocrine ◽  
2019 ◽  
Vol 64 (1) ◽  
pp. 184-195
Author(s):  
Yanlong Liang ◽  
Yanzhi Liu ◽  
Wenxiu Lai ◽  
Minqun Du ◽  
Shuhui Li ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Vitamin D3 ◽  
Muscle Quality ◽  
Diabetes Model ◽  
1,25 Dihydroxy Vitamin D3

scholarly journals Decoding Neural Metabolic Markers From the Carotid Sinus Nerve in a Type 2 Diabetes Model

2019 ◽  
Vol 27 (10) ◽  
pp. 2034-2043 ◽  
Author(s):  
Marina Cracchiolo ◽  
Joana F. Sacramento ◽  
Alberto Mazzoni ◽  
Alessandro Panarese ◽  
Jacopo Carpaneto ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Carotid Sinus ◽  
Carotid Sinus Nerve ◽  
Metabolic Markers ◽  
Diabetes Model
Sign in / Sign up

Export Citation Format

Share Document